PACB (STOCKS)
Pacific Biosciences of California, Inc.
$1.810000
+0.000000 (+0.00%)
Prev close: $1.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christian O. Henry
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $552.49M
- Employees
- 575
- P/E (TTM)
- -0.85
- P/B (TTM)
- 15.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $154.58M |
| Benefits Costs and Expenses | $657.79M |
| Cost Of Revenue | $115.31M |
| Costs And Expenses | $657.79M |
| Gross Profit | $39.27M |
| Operating Expenses | $704.96M |
| Selling, General, and Administrative Expenses | $149.08M |
| Research and Development | $101.89M |
| Other Operating Expenses | $453.99M |
| Operating Income/Loss | -$665.69M |
| Income/Loss From Continuing Operations After Tax | -$503.63M |
| Income/Loss From Continuing Operations Before Tax | -$503.20M |
| Income Tax Expense/Benefit | $432.00K |
| Net Income/Loss | -$503.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$503.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$503.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.67 |
| Diluted Earnings Per Share | -$2.13 |
| Basic Average Shares | 302,160,000 |
| Diluted Average Shares | 316,038,000 |
| Assets | $803.16M |
| Current Assets | $394.24M |
| Inventory | $53.15M |
| Other Current Assets | $341.08M |
| Noncurrent Assets | $408.92M |
| Fixed Assets | $22.13M |
| Intangible Assets | $16.14M |
| Other Non-current Assets | $370.65M |
| Liabilities | $767.07M |
| Current Liabilities | $63.21M |
| Accounts Payable | $16.36M |
| Other Current Liabilities | $46.85M |
| Noncurrent Liabilities | $703.86M |
| Equity | $36.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $36.09M |
| Liabilities And Equity | $803.16M |
| Net Cash Flow From Operating Activities | -$122.79M |
| Net Cash Flow From Operating Activities, Continuing | -$122.79M |
| Net Cash Flow From Investing Activities | $147.66M |
| Net Cash Flow From Investing Activities, Continuing | $147.66M |
| Net Cash Flow From Financing Activities | -$46.77M |
| Net Cash Flow From Financing Activities, Continuing | -$46.77M |
| Net Cash Flow | -$21.91M |
| Net Cash Flow, Continuing | -$21.91M |
| Comprehensive Income/Loss | -$504.77M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$504.77M |
| Other Comprehensive Income/Loss | -$504.77M |